Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.26 USD | +7.40% | +5.68% | -0.82% |
Financials (USD)
Sales 2024 * | 23.95M | Sales 2025 * | 72.18M | Capitalization | 308M |
---|---|---|---|---|---|
Net income 2024 * | -76M | Net income 2025 * | -39M | EV / Sales 2024 * | 12.9 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 4.27 x |
P/E ratio 2024 * |
-4.68
x | P/E ratio 2025 * |
-9.19
x | Employees | 100 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 44.08% |
Latest transcript on Verrica Pharmaceuticals Inc.
1 day | +7.40% | ||
1 week | +5.68% | ||
Current month | +4.24% | ||
1 month | +7.88% | ||
3 months | +38.55% | ||
6 months | +81.50% | ||
Current year | -0.82% |
Managers | Title | Age | Since |
---|---|---|---|
Ted White
CEO | Chief Executive Officer | 59 | 17-11-30 |
Terence Kohler
DFI | Director of Finance/CFO | 46 | 21-07-15 |
Compliance Officer | 60 | 18-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Prygocki
BRD | Director/Board Member | 58 | 18-04-30 |
Paul Manning
CHM | Chairman | 68 | 15-11-30 |
Craig Ballaron
BRD | Director/Board Member | 63 | 19-06-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +2.67% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 7.26 | +7.40% | 301,095 |
24-05-02 | 6.76 | -1.31% | 188,194 |
24-05-01 | 6.85 | -1.65% | 177,091 |
24-04-30 | 6.965 | -2.59% | 245,727 |
24-04-29 | 7.15 | +4.08% | 373,313 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.82% | 308M | |
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B |
- Stock Market
- Equities
- VRCA Stock